Clinical Trial

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Name: Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients — clinical trial record (NCT06562894)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of different doses of SYHX1901 tablets in the treatment of severe alopecia areata.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-08-18; most recent amendment 2025-05-28.

Trial Details

NCT Number	NCT06562894
Lead Sponsor	CSPC Ouyi Pharmaceutical Co., Ltd. Collaborators: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions	Severe Alopecia Areata
Enrollment	156 participants
Start Date	2025-05-26
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-11-17 (estimated)
Updated on ClinicalTrials.gov	2025-06-03